• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合多组学分析描述了缺血性心力衰竭中的免疫特征,并将PTN鉴定为一种新型生物标志物。

Integrated multi-omics analysis describes immune profiles in ischemic heart failure and identifies PTN as a novel biomarker.

作者信息

Xiong Ting, Li Quhuan, Wang Yifan, Kong Ying, Li Hailin, Liu Jie, Wu Yueheng, Zhang Fengxia

机构信息

School of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China.

Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

出版信息

Front Mol Biosci. 2024 Dec 11;11:1524827. doi: 10.3389/fmolb.2024.1524827. eCollection 2024.

DOI:10.3389/fmolb.2024.1524827
PMID:39722892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11668632/
Abstract

INTRODUCTION

Heart failure is a leading global cause of mortality, with ischemic heart failure (IHF) being a major contributor. IHF is primarily driven by coronary artery disease, and its underlying mechanisms are not fully understood, particularly the role of immune responses and inflammation in cardiac muscle remodeling. This study aims to elucidate the immune landscape of heart failure using multi-omics data to identify biomarkers for preventing cardiac fibrosis and disease progression.

METHODS

We utilized multi-omics data to elucidate the intricate immune landscape of heart failure at various regulatory levels. Given the substantial size of our transcriptomic dataset, we used diverse machine learning techniques to identify key mRNAs. For smaller datasets such as our proteomic dataset, we applied multilevel data cleansing and enhancement using principles from network biology. This comprehensive analysis led to the development of a scalable, integrated -omics analysis pipeline.

RESULTS

Pleiotrophin (PTN) had shown significant upregulation in multiple datasets and the activation of various molecules associated with dysplastic cardiac remodeling. By synthesizing these data with experimental validations, PTN was identified as a potential biomarker.

DISCUSSION

The present study not only provides a comprehensive perspective on immune dynamics in IHF but also offers valuable insights for the identification of biomarkers, discovery of therapeutic targets, and development of drugs.

摘要

引言

心力衰竭是全球主要的死亡原因,缺血性心力衰竭(IHF)是主要促成因素。IHF主要由冠状动脉疾病驱动,其潜在机制尚未完全了解,尤其是免疫反应和炎症在心肌重塑中的作用。本研究旨在利用多组学数据阐明心力衰竭的免疫格局,以识别预防心脏纤维化和疾病进展的生物标志物。

方法

我们利用多组学数据在各个调控水平阐明心力衰竭复杂的免疫格局。鉴于我们转录组数据集的规模庞大,我们使用了多种机器学习技术来识别关键mRNA。对于像我们蛋白质组数据集这样较小的数据集,我们应用网络生物学原理进行多级数据清理和增强。这种全面分析促成了一个可扩展的综合组学分析流程的开发。

结果

多效生长因子(PTN)在多个数据集中显示出显著上调,并且与发育异常的心脏重塑相关的各种分子被激活。通过将这些数据与实验验证相结合,PTN被确定为一种潜在的生物标志物。

讨论

本研究不仅提供了关于IHF免疫动态的全面观点,还为生物标志物的识别、治疗靶点的发现和药物的开发提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/4bd579064e41/fmolb-11-1524827-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/a03d20505e96/fmolb-11-1524827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/dcb620dd26df/fmolb-11-1524827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/45c98d4f3e0c/fmolb-11-1524827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/d950c080f494/fmolb-11-1524827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/dda9b67313c3/fmolb-11-1524827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/c770f6a4bf13/fmolb-11-1524827-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/4bd579064e41/fmolb-11-1524827-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/a03d20505e96/fmolb-11-1524827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/dcb620dd26df/fmolb-11-1524827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/45c98d4f3e0c/fmolb-11-1524827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/d950c080f494/fmolb-11-1524827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/dda9b67313c3/fmolb-11-1524827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/c770f6a4bf13/fmolb-11-1524827-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e61/11668632/4bd579064e41/fmolb-11-1524827-g007.jpg

相似文献

1
Integrated multi-omics analysis describes immune profiles in ischemic heart failure and identifies PTN as a novel biomarker.综合多组学分析描述了缺血性心力衰竭中的免疫特征,并将PTN鉴定为一种新型生物标志物。
Front Mol Biosci. 2024 Dec 11;11:1524827. doi: 10.3389/fmolb.2024.1524827. eCollection 2024.
2
Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches.解析 COVID-19 感染与缺血性心力衰竭合并症之间的分子串扰和免疫图谱:对诊断生物标志物和治疗方法的新见解。
Cell Signal. 2023 Dec;112:110909. doi: 10.1016/j.cellsig.2023.110909. Epub 2023 Sep 28.
3
Combining WGCNA and machine learning to identify mechanisms and biomarkers of ischemic heart failure development after acute myocardial infarction.结合加权基因共表达网络分析(WGCNA)和机器学习来识别急性心肌梗死后缺血性心力衰竭发生发展的机制和生物标志物。
Heliyon. 2024 Feb 27;10(5):e27165. doi: 10.1016/j.heliyon.2024.e27165. eCollection 2024 Mar 15.
4
Insights into therapeutic targets and biomarkers using integrated multi-'omics' approaches for dilated and ischemic cardiomyopathies.采用整合多组学方法研究扩张型和缺血性心肌病的治疗靶点和生物标志物。
Integr Biol (Camb). 2021 May 18;13(5):121-137. doi: 10.1093/intbio/zyab007.
5
A multi-omics approach identifies the key role of disorders of sphingolipid metabolism in Ang II-induced hypertensive cardiomyopathy myocardial remodeling.一种多组学方法确定了鞘脂代谢紊乱在血管紧张素II诱导的高血压性心肌病心肌重塑中的关键作用。
Sci Rep. 2024 Dec 5;14(1):30379. doi: 10.1038/s41598-024-81611-8.
6
Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers.结合多组学数据和网络算法的机器学习可识别肾上腺皮质癌预后生物标志物。
Front Mol Biosci. 2023 Nov 6;10:1258902. doi: 10.3389/fmolb.2023.1258902. eCollection 2023.
7
Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.在整合的平行多组学数据集中识别1型糖尿病复合生物标志物特征的监督参数学习
Biomedicines. 2024 Feb 22;12(3):492. doi: 10.3390/biomedicines12030492.
8
Bioinformatics combining machine learning and single-cell sequencing analysis to identify common mechanisms and biomarkers of rheumatoid arthritis and ischemic heart failure.生物信息学结合机器学习和单细胞测序分析以识别类风湿性关节炎和缺血性心力衰竭的共同机制及生物标志物。
Heliyon. 2025 Jan 9;11(2):e41641. doi: 10.1016/j.heliyon.2025.e41641. eCollection 2025 Jan 30.
9
FAM210A Regulates Mitochondrial Translation and Maintains Cardiac Mitochondrial Homeostasis.FAM210A调节线粒体翻译并维持心脏线粒体稳态。
bioRxiv. 2023 May 22:2023.05.20.541585. doi: 10.1101/2023.05.20.541585.
10
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure.多组学时代的心脏纤维化:对心力衰竭的影响
Circ Res. 2025 Mar 28;136(7):773-802. doi: 10.1161/CIRCRESAHA.124.325402. Epub 2025 Mar 27.

引用本文的文献

1
Zinc and its binding proteins: essential roles and therapeutic potential.锌及其结合蛋白:重要作用与治疗潜力
Arch Toxicol. 2025 Jan;99(1):23-41. doi: 10.1007/s00204-024-03891-3. Epub 2024 Nov 7.

本文引用的文献

1
Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation.免疫细胞推动心肌梗死的新型免疫调节治疗:从基础到临床转化。
Front Immunol. 2023 Jan 24;14:1097295. doi: 10.3389/fimmu.2023.1097295. eCollection 2023.
2
The role of major immune cells in myocardial infarction.主要免疫细胞在心肌梗死中的作用。
Front Immunol. 2023 Jan 19;13:1084460. doi: 10.3389/fimmu.2022.1084460. eCollection 2022.
3
Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
合并阿片类物质使用障碍的心力衰竭患者中缺血性和非缺血性心肌病临床结局的差异
Curr Probl Cardiol. 2023 May;48(5):101609. doi: 10.1016/j.cpcardiol.2023.101609. Epub 2023 Jan 21.
4
Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease.预测心脏病患者临床结局的新兴生物标志物
Life (Basel). 2023 Jan 13;13(1):230. doi: 10.3390/life13010230.
5
Progress in Clinical Gene Therapy for Cardiac Disorders.心脏疾病的临床基因治疗进展。
Mol Diagn Ther. 2023 Mar;27(2):179-191. doi: 10.1007/s40291-022-00632-z. Epub 2023 Jan 15.
6
IRF1/ZNF350/GPX4-mediated ferroptosis of renal tubular epithelial cells promote chronic renal allograft interstitial fibrosis.IRF1/ZNF350/GPX4 介导的肾小管上皮细胞铁死亡促进慢性肾移植间质纤维化。
Free Radic Biol Med. 2022 Nov 20;193(Pt 2):579-594. doi: 10.1016/j.freeradbiomed.2022.11.002. Epub 2022 Nov 7.
7
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy.人类扩张型和肥厚型心肌病的单细胞分析。
Nature. 2022 Aug;608(7921):174-180. doi: 10.1038/s41586-022-04817-8. Epub 2022 Jun 22.
8
Global burden of heart failure: a comprehensive and updated review of epidemiology.心力衰竭的全球负担:流行病学的全面更新综述
Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013.
9
Identification of cardiomyopathy-related core genes through human metabolic networks and expression data.通过人类代谢网络和表达数据鉴定心肌病相关核心基因。
BMC Genomics. 2022 Jan 12;23(1):47. doi: 10.1186/s12864-021-08271-0.
10
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.细胞外基质在心力衰竭中的作用:ADAMTS5 在蛋白聚糖重塑中的作用。
Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22.